30 related articles for article (PubMed ID: 38660841)
1. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes.
Gao Y; Jin F; Zhang P; Zheng C; Zheng X; Xie J; Lu Y; Tong X; Du J; Zhang J; Wang Y
Biomed Pharmacother; 2024 Jun; 175():116727. PubMed ID: 38733771
[TBL] [Abstract][Full Text] [Related]
2. Qiju Dihuang Pill protects the lens epithelial cells via alleviating cuproptosis in diabetic cataract.
Yang J; Gao Y; Mao H; Kuang X; Tian F
J Ethnopharmacol; 2024 Jun; 333():118444. PubMed ID: 38851473
[TBL] [Abstract][Full Text] [Related]
3. GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes.
Li H; Li Y; Yu Y; Ren X; Yang C; Jin W; Li K; Zhou Y; Wu C; Shen Y; Hu W; Liu Y; Yu L; Tong X; Du J; Wang Y
Free Radic Biol Med; 2024 Jun; 222():130-148. PubMed ID: 38866192
[TBL] [Abstract][Full Text] [Related]
4. Biomimetic copper-doped polypyrrole nanoparticles induce glutamine metabolism inhibition to enhance breast cancer cuproptosis and immunotherapy.
Zhang N; Ping W; Rao K; Zhang Z; Huang R; Zhu D; Li G; Ning S
J Control Release; 2024 May; 371():204-215. PubMed ID: 38810704
[TBL] [Abstract][Full Text] [Related]
5. Copper's dual role: unravelling the link between copper homeostasis, cuproptosis, and cardiovascular diseases.
Parsanathan R
Hypertens Res; 2024 May; 47(5):1440-1442. PubMed ID: 38467792
[TBL] [Abstract][Full Text] [Related]
6. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy.
Zheng P; Zhou C; Lu L; Liu B; Ding Y
J Exp Clin Cancer Res; 2022 Sep; 41(1):271. PubMed ID: 36089608
[TBL] [Abstract][Full Text] [Related]
7. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer.
Yang W; Wang Y; Huang Y; Yu J; Wang T; Li C; Yang L; Zhang P; Shi L; Yin Y; Tao K; Li R
Biomed Pharmacother; 2023 Mar; 159():114301. PubMed ID: 36706634
[TBL] [Abstract][Full Text] [Related]
8. [Effects of
Li Y; Shi LH; Xie X; Fan PK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1599-1607. PubMed ID: 38071034
[TBL] [Abstract][Full Text] [Related]
9. Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer Immunotherapy.
Guo B; Yang F; Zhang L; Zhao Q; Wang W; Yin L; Chen D; Wang M; Han S; Xiao H; Xing N
Adv Mater; 2023 Jun; 35(22):e2212267. PubMed ID: 36916030
[TBL] [Abstract][Full Text] [Related]
10. Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2.
Xu B; Wang S; Li R; Chen K; He L; Deng M; Kannappan V; Zha J; Dong H; Wang W
Cell Death Dis; 2017 May; 8(5):e2797. PubMed ID: 28518151
[TBL] [Abstract][Full Text] [Related]
11. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia.
Li Y; Kan X
Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332
[TBL] [Abstract][Full Text] [Related]
12. [Elesclomol-Cu Induces Cuproptosis in Human Acute Myeloid Leukemia Cells].
Yu YH; Li HJ; Yang XY; Yu LY; Tong XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):389-394. PubMed ID: 38660841
[TBL] [Abstract][Full Text] [Related]
13. Novel insights into anticancer mechanisms of elesclomol: More than a prooxidant drug.
Gao J; Wu X; Huang S; Zhao Z; He W; Song M
Redox Biol; 2023 Nov; 67():102891. PubMed ID: 37734229
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]